Lupeol alleviates atopic dermatitis-like skin inflammation in 2,4-dinitrochlorobenzene/Dermatophagoides farinae extract-induced mice. 2023

Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
CMRI, Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects from children to adults widely, presenting symptoms such as pruritus, erythema, scaling, and dryness. Lupeol, a pentacyclic triterpenoid, has anti-inflammatory and antimicrobial activities. Based on these properties, the therapeutic effects of lupeol on skin disorders have been actively studied. In the present study, we aimed to determine the effectiveness of lupeol on AD. We utilized tumor necrosis factor (TNF)-α/interferon (IFN)-γ-stimulated keratinocytes and 2, 4-dinitrochlorobenzene/Dermatophagoides farinae extract (DFE)-induced AD mice to confirm the action. Lupeol inhibited TNF-α/IFN-γ-stimulated keratinocytes activation by reducing the expressions of pro-inflammatory cytokines and chemokines which are mediated by the activation of signaling molecules such as signal transducer and activator of transcription 1, mitogen-activated protein kinases (p38 and ERK), and nuclear factor-κB. Oral administration of lupeol suppressed epidermal and dermal thickening and immune cell infiltration in ear tissue. Immunoglobulin (Ig) E (total and DFE-specific) and IgG2a levels in serum were also reduced by lupeol. The gene expression and protein secretion of T helper (Th) 2 cytokines, Th1 cytokines, and pro-inflammatory cytokine in ear tissue were decreased by lupeol. These results suggest that lupeol has inhibitory effects on AD-related responses. Therefore, lupeol could be a promising therapeutic agent for AD.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
May 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
January 2021, Animal cells and systems,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
January 2024, Journal of ethnopharmacology,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
July 2021, Molecules (Basel, Switzerland),
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
August 2014, Journal of medicinal food,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
November 2021, Journal of ethnopharmacology,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
July 2018, BMC complementary and alternative medicine,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
April 2015, Pharmaceutical biology,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
February 2017, Food chemistry,
Sojung Bae, and Na-Hee Jeong, and Young-Ae Choi, and Byungheon Lee, and Yong Hyun Jang, and Soyoung Lee, and Sang-Hyun Kim
September 2015, International journal of molecular sciences,
Copied contents to your clipboard!